Myosin light polypeptide 6 (MYL6) is an essential light chain of non-muscle myosin II. Learn MYL6's structure, function, gene location, and clinical research.
Myosin light polypeptide 6 (MYL6) is an essential light chain that binds the neck region of myosin II and helps stabilize the protein's lever arm. It is encoded by the MYL6 gene on human chromosome 12 and is present in non-muscle cells and smooth muscle cells throughout the body. MYL6 is a normal human protein, not a therapeutic peptide, hormone, or supplement ingredient.
What Is Myosin Light Polypeptide 6?
MYL6 is the gene and protein symbol for one of the alkali light chains of myosin, the "essential" light chains that sit alongside the regulatory light chain on the myosin heavy chain. Cells rely on it wherever non-muscle myosin II does mechanical work, including cell division, migration, and maintenance of cell shape.
Key identifiers for the human protein:
- Gene: MYL6, located at chromosome 12q13.2
- Protein size: roughly 17 kDa; the main isoform is 151 amino acids long
- UniProt entry: P60660 (human MYL6)
- Common aliases: MLC3, LC17, myosin alkali light chain 6, essential light chain (ELC)
- Tissue pattern: broadly expressed, with higher levels in tissues that undergo constant cytoskeletal remodeling
Alternative splicing of the MYL6 transcript produces more than one isoform, which is one reason different papers report slightly different molecular weights. MYL6B is a separate, related gene and should not be confused with MYL6.
MYL6 Structure and Molecular Features
The protein is elongated and largely alpha-helical, built from four helix-loop-helix motifs of the EF-hand type. Two of those regions contact the IQ motifs on the myosin heavy chain, anchoring the light chain into the lever arm that amplifies the motor's power stroke.
Understanding the polypeptide structure explains the behavior: the elongated shape lets MYL6 act as a rigid extension of the heavy chain rather than as an enzyme. MYL6 has no catalytic activity of its own and does not phosphorylate other proteins.
The polypeptide vs protein distinction is worth keeping straight here. A polypeptide is simply a chain of amino acids, while a protein is one or more folded polypeptide chains performing a defined job. MYL6 is a small, single-chain protein that folds around the myosin heavy chain neck.
What Does MYL6 Do?
The polypeptide function of MYL6 is primarily structural and mechanical. Reducing the essential light chain weakens myosin's ability to move actin filaments, which shows up in laboratory models as defects in cell movement and cell division.
Documented and proposed roles include:
- Stabilizing the myosin II lever arm so the motor generates consistent force
- Supporting cytokinesis, the final pinch that separates two daughter cells
- Contributing to cell migration, wound closure, and focal adhesion turnover
- Helping maintain the actin cytoskeleton and cell shape under tension
- Appearing in the contractile machinery of smooth muscle and platelets
MYL6 belongs to the EF-hand superfamily, the same broad family that includes calmodulin and troponin C.
MYL6 vs the regulatory light chain
This is the most common point of confusion. The essential light chain, which includes MYL6 in non-muscle myosin, is structural, while the regulatory light chain controls when the motor turns on.
The regulatory light chain is switched by phosphorylation, mainly through myosin light chain kinase (MLCK) and Rho-kinase, and it is a different protein from MYL6. MYL6 is not the substrate that MLCK phosphorylates.
| Component | Representative genes | Approximate size | Primary role | Main regulation |
|---|---|---|---|---|
| Essential light chain (MYL6) | MYL6 | ~17 kDa | Stabilizes the lever arm | Mostly structural; not phosphorylation-driven |
| Non-muscle regulatory light chain | MYL12A, MYL12B | ~20 kDa | Switches motor activity on and off | Phosphorylation by MLCK and Rho-kinase |
| Smooth muscle regulatory light chain | MYL9 | ~20 kDa | Activates smooth muscle contraction | Calcium/calmodulin-dependent MLCK |
| Myosin heavy chain | MYH9, MYH10, MYH11 | ~200 kDa and up | ATPase motor, actin binding, filament assembly | Heavy-chain phosphorylation, assembly state |
MYL6 in Health and Disease Research
MYL6 has drawn interest mainly as a laboratory marker rather than a clinical tool. Several studies report altered MYL6 levels in tumor tissue, including lung, liver, and breast cancers, and some authors have proposed it as a candidate biomarker.
Those findings remain preliminary and inconsistent across cohorts. MYL6 is not an approved diagnostic test, and no therapy in the United States is designed to target MYL6 directly.
Researchers also study MYL6 in cardiovascular biology, platelet function, and developmental models in which the cytoskeleton is disrupted. Most of this work uses cell culture, animal models, or human tissue samples rather than patients.
Is Myosin Light Polypeptide 6 Sold as a Supplement?
No. MYL6 is not a dietary supplement, a hormone, or an approved drug. It is available only as research-grade recombinant protein for laboratory experiments, and suppliers typically label it for research use only.
People sometimes confuse MYL6 with commercial peptides because of the word "polypeptide." Common polypeptide examples include insulin, oxytocin, and glucagon, which are regulated prescription drugs, and MYL6 is not in that category.
Large-scale manufacturers such as PolyPeptide supply synthetic peptides for pharmaceutical clients. Recombinant proteins like MYL6 are produced in cells rather than by chemical synthesis, which is why they come from protein suppliers instead.
Anyone considering a peptide product for a health concern should talk with a healthcare professional first, since unapproved peptides sold online carry real risks of contamination, dosing errors, and unknown effects.
Key Takeaways
- Myosin light polypeptide 6 is an essential light chain of myosin II encoded by the MYL6 gene at chromosome 12q13.2.
- MYL6 stabilizes the myosin lever arm and supports cell division, migration, and cytoskeletal tension.
- MYL6 is a different protein from the regulatory light chain that myosin light chain kinase phosphorylates.
- MYL6 is a normal human protein, not a supplement, and it is not FDA-approved for human use as a drug.
- MYL6 research is mostly preclinical and laboratory-based, so firm clinical conclusions remain limited.
Frequently Asked Questions
What does myosin light polypeptide 6 do?
MYL6 is the essential light chain of myosin II. It binds the myosin heavy chain neck and stabilizes the lever arm, which helps the motor move actin filaments during cell division, migration, and shape changes. Unlike the regulatory light chain, MYL6 is not switched on and off by phosphorylation.
Is myosin light polypeptide 6 the same as the regulatory light chain?
No. MYL6 is an essential light chain, while the regulatory light chain is a separate protein encoded by genes such as MYL9, MYL12A, and MYL12B. Myosin activity is regulated mainly by phosphorylation of the regulatory light chain by myosin light chain kinase, not by MYL6.
Can you buy myosin light polypeptide 6 as a supplement?
No. MYL6 is not a dietary supplement or an FDA-approved drug. It is sold only as research-grade recombinant protein for laboratory use, and anything marketed online as an MYL6 supplement should be treated as unverified and potentially unsafe.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.